Kenny Crouch

CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases

ApotheCom Associates LLC specializes in providing innovative and excellent medical affairs and medical education services to pharmaceutical and biotech companies. The private company is based in Yardley, PA. David Dunn has been the CEO of the company since 2010. The company's approach is evidence-based and focused on accelerating outcomes.